The results of this study will provide more insight into the molecular defect of adiponectin underlying T2D pathogenesis and a potential therapeutic approach based on a targeted molecule and specific molecular mechanism. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.